These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
375 related items for PubMed ID: 2184527
21. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H. Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [Abstract] [Full Text] [Related]
23. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report. Am Rev Respir Dis; 1978 Aug; 118(2):219-28. PubMed ID: 100029 [Abstract] [Full Text] [Related]
24. Short-course chemotherapy of pulmonary tuberculosis in pneumoconiotic patients. Lin TP, Suo J, Lee CN, Lee JJ, Yang SP. Am Rev Respir Dis; 1987 Oct; 136(4):808-10. PubMed ID: 3310770 [Abstract] [Full Text] [Related]
25. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre. Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448 [Abstract] [Full Text] [Related]
26. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis. Pérez-Guzmán C, Vargas MH, Martínez-Rossier LA, Torres-Cruz A, Villarreal-Velarde H. Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119 [Abstract] [Full Text] [Related]
27. Fixed dose combination short course chemotherapy in the treatment of pulmonary tuberculosis. Wolde K, Lema E, Roscigno G, Abdi A. Ethiop Med J; 1992 Apr; 30(2):63-8. PubMed ID: 1345030 [Abstract] [Full Text] [Related]
28. Five-year follow-up of a clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council. Am Rev Respir Dis; 1988 May; 137(5):1147-50. PubMed ID: 2904237 [Abstract] [Full Text] [Related]
29. [Randomized control study on domestic fixed-dose combinations in the initial treatment of smears positive tuberculosis]. Xu WG, Lu W, He HJ, Gu XR. Zhonghua Jie He He Hu Xi Za Zhi; 2004 Oct; 27(10):690-3. PubMed ID: 16201049 [Abstract] [Full Text] [Related]
30. A controlled trial of a 4-weekly supplement of rifampicin, pyrazinamide and streptomycin in the continuation phase of a 7-month daily chemotherapy regimen for pulmonary tuberculosis. Tanzania/British Medical Research Council Collaborative Investigation. S Afr Med J; 1996 Aug; 86(8):960-5. PubMed ID: 8823423 [Abstract] [Full Text] [Related]
31. Evaluation of the 3-drug combination, Rifater, versus 4-drug therapy in the ambulatory treatment of tuberculosis in Cape Town. Macnab MF, Bohmer PD, Seager JR. S Afr Med J; 1994 Jun; 84(6):325-8. PubMed ID: 7740377 [Abstract] [Full Text] [Related]
33. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. API Consensus Expert Committee. J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350 [Abstract] [Full Text] [Related]
34. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months. Nolan CM, Goldberg SV. Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140 [Abstract] [Full Text] [Related]
35. Bioavailability of isoniazid, rifampicin and pyrazinamide (in free combination or fixed-triple formulation) in intermittent antituberculous chemotherapy. Acocella G, Luisetti M, Grassi GG, Peona V, Pozzi E, Grassi C. Monaldi Arch Chest Dis; 1993 Nov; 48(3):205-9. PubMed ID: 8369784 [Abstract] [Full Text] [Related]
37. A comparison of two short course tuberculosis chemotherapy regimens, both using Rifater during an intensive phase, with a 3 year follow-up. Punnotok J, Pumprueg U, Chakorn T. J Med Assoc Thai; 1995 Jun; 78(6):298-304. PubMed ID: 7561554 [Abstract] [Full Text] [Related]
39. Supervised six-months treatment of newly diagnosed pulmonary tuberculosis using isoniazid, rifampin, and pyrazinamide with and without streptomycin. Snider DE, Graczyk J, Bek E, Rogowski J. Am Rev Respir Dis; 1984 Dec; 130(6):1091-4. PubMed ID: 6508006 [Abstract] [Full Text] [Related]
40. [The effectiveness of pyrazinamide-containing six-month short course chemotherapy]. Wada M. Kekkaku; 2000 Nov; 75(11):665-73. PubMed ID: 11140090 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]